green tick

Four batches of EpiPen recalled

0 comments Read Later

Four batches of EpiPen recalled

Pharmacists have been advised that four batches of potentially faulty EpiPen 300mg adrenaline auto-injectors are being recalled

The TGA and Alphapharm issued an alert on Monday, saying that EpiPens from the affected batches may contain a faulty part and could fail to activate or require more force than usual to activate.

“There have been two confirmed reports of auto-injectors from these batches failing to activate correctly worldwide from approximately 80,000 devices distributed,” the TGA says.

“The proportion of these auto-injectors that have been used is not known."

The affected batch numbers are 5FA665, 5FA6651, 5FA6652 or 5FA6653 and all expire in April 2017.

Consumers are being urged to take the faulty EpiPens back to their local pharmacy for a replacement or a refund.

However, they should be advised to keep their current anti-injector until they get a replacement and use it if required, being mindful that they may need to apply more force that normal to activate it.

No other batches, including the EpiPen Jr 150mcg, have been affected by the faulty part and are not subject to this recall.

More information:

TGA alert


 

 Subscribe to our Newsletter


 Breaking news and special features
 A daily must-read for pharmacists
 Delivered to your inbox
By filling in your email address and clicking submit with this option selected, you agree to receive email communications from us relevant to the healthcare industry. You always have the option of unsubscribing later via an unsubscribe link or your subscriptions management page. View our privacy policy here.

Your profile is
0% complete


 
 

Pharmacy News on Twitter

­

My list
  •  
Read Later